SCM
CMPX icon

Sterling Capital Management’s Compass Therapeutics CMPX Stock Holding History

Sterling Capital Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.9K Sell
2,444
-1,383
-36% -$7.98K ﹤0.01% 2241
2025
Q4 		$20.6K Buy
3,827
+492
+15% +$2.27K ﹤0.01% 2210
2025
Q3 		$11.7K Buy
3,335
+2,060
+162% +$6.51K ﹤0.01% 2408
2025
Q2 		$3.31K Sell
1,275
-485
-28% -$1K ﹤0.01% 2733
2025
Q1 		$3.34K Sell
1,760
-1,704
-49% -$4.53K ﹤0.01% 2361
2024
Q4 		$5.02K Buy
3,464
+3,140
+969% +$5.21K ﹤0.01% 2467
2024
Q3 		$596 Buy
+324
New +$404 ﹤0.01% 2787

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM